RCHY1 and hepatocellular carcinoma: Pirh2 was repeatedly shown to be a prognostic marker for hepatocellular carcinoma (HCC) since both mRNA and protein levels of Pirh2 were elevated in HCC tissue samples compared to both normal or pre-malignant paracarcinomatous liver tissues [184].